Search - tctmd.com

Displaying 281 - 300 of 424

Sort: Relevancy | Date

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

Todd Neale

February 16, 2021

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave

Shelley Wood

January 22, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

Shelley Wood

December 28, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

Top Stories in Cardiology: November 2020

Podcast Heart Sounds

CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures

Shelley Wood

November 24, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

News Conference News AHA 2020

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

Todd Neale

November 13, 2020

News Daily News

Clinical Trial Conduct in the COVID-19 Era: A Road Map

Todd Neale

November 12, 2020

News Daily News

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Michael O'Riordan

October 30, 2020

News Daily News

Heart Failure Doubles Risk of Dying From COVID-19

L.A. McKeown

October 30, 2020

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

Advertisement

March 2021 News Roundup

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

February 2021 News Roundup

Same Drop in MI, HF Admissions Seen in COVID-19’s Second Wave

FDA Approves Vericiguat for High-risk Patients With HF

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

The Biggest News of 2020: TCTMD’s Top 10

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

More Women Than Men Develop HF or Die After STEMI

TCTMD’s Top 10 Most Popular Stories for November 2020

Top Stories in Cardiology: November 2020

CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

Clinical Trial Conduct in the COVID-19 Era: A Road Map

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Heart Failure Doubles Risk of Dying From COVID-19

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content